Form 4 for GYRE GYRE THERAPEUTICS, INC.

Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-30 · accession 0001140361-24-050588 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MTI	2024-12-30	2024-12-26+	GYRE	Ma Songjiang	Pres, Dir	S - Sale	$12.64	-4,000	2.93M	-0.1%	-$50.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-12-26	S	D	356	$13.05	2,928,467	I By Spouse	—	—	(F3) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $13.00 to $13.13. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2024-12-27	S	D	2,000	$12.58	2,926,467	I By Spouse	—	—	(F4) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $12.40 to $13.14. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
3	Common	Common Stock	2024-12-26	S	D	1,644	$12.62	2,928,823	I By Spouse	—	—	(F2) The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.97. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.